Viewing Study NCT05864534

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:28 AM
Ignite Modification Date: 2026-01-27 @ 5:14 AM
Study NCT ID: NCT05864534
Status: RECRUITING
Last Update Posted: 2025-10-03
First Post: 2023-05-09
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma
Sponsor: Northwestern University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Newly Diagnosed Glioblastoma View
None Glioblastoma, Isocitric Dehydrogenase (IDH)-Wildtype View
None Gliosarcoma View
None Glioblastoma Multiforme View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Immunotherapy View
None Ultrasound View
None Blood-brain barrier View
None Sonocloud View
None Balstilimab (BAL) View
None Botensilimab (BOT) View
None Doxorubicin (DOX) View